Synapse Medicine Initiates Multi-Site Implementation Study wit... - 07 October 2022 02:00

NEW YORK, Oct. 6, 2022, /PRNewswire-AsiaNet/ -- • Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency. • The Synapse Medicine medica...

  TauRx Announces Results from Phase 3 Alzheimer's Disease Study... - 06 October 2022 21:00

ABERDEEN, Scotland and SINGAPORE, Oct. 6, 2022 /PRNewswire-AsiaNet/ -- - For people with early Alzheimer's (MCI), HMTM treatment resulted in sustained improvement in cognition over pre-treatment baseline, and normalisation of brain atrophy to a rate similar to healthy individuals - For people with mild to moderate A...

  Servier unveils its 2030 ambition and reveals a new visual ide... - 06 October 2022 17:30

PARIS, Oct. 6, 2022 /PRNewswire-AsiaNet/ -- A new ambition by 2030 to accelerate its transformation dynamic A visual identity, a marker of the successful transformation of the Group, its ambitions and its renewal Servier today unveils its 2030 ambition as well as a new visual identity ...

  Global Milk Industry Digestibility Breakthrough - 05 October 2022 07:00

BRISBANE,Oct.5/Medianet International-AsiaNet/-- --World-first Haelen technology achieves 100% fresh, natural milk that is twice as digestible Naturo, the company behind the world-first patented 'Haelen' milk processing technology which gives fresh milk a 60-day shelf life has achieved anoth...

  Cambrex Announces Stability Storage Expansions in Ireland and... - 04 October 2022 18:00

EAST RUTHERFORD, NJ, Oct. 4, 2022 /PRNewswire-AsiaNet/ -- Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will ope...

  Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Ga... - 04 October 2022 17:00

OKAYAMA, Japan, Oct. 4, 2022 /Kyodo JBN-AsiaNet/ -- Hayashibara Co., Ltd., a member of Nagase Group and headquartered in Okayama City, western Japan, hosted the 24th Trehalose Symposium, with the support of the Japanese Society of Applied Glycoscience, on September 8, 2022. Photo: https://kyodon...

  Climate Change And Health Inequity A Deadly Mix For The Most V... - 29 September 2022 08:01

GENEVA, Sept. 29, 2022 /PRNewswire-AsiaNet/ On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, saying millions more lives are now at risk from cardiovascular disease, which is still the world's biggest killer. Climate ...

  ABILITY DIABETES GLOBAL – A Landmark RCT in the field of PCI f... - 28 September 2022 22:47

TAMPA, Fla., Sept. 28, 2022 /PRNewswire- AsiaNet/- ABILITY DIABETES-GLOBAL [https://www.conceptmedical.com/clinical-program/ability-diabetes-global/](ADG), is the World's largest Randomized Controlled Trial (RCT) for patients with DM (Diabetes Mellitus), comparing head-to-head the Sirolimus el...

  Pharming Announces US FDA Acceptance for Priority Review of it... - 28 September 2022 16:00

LEIDEN, The Netherlands, Sep 28, 2022, /PRNewswire-AsiaNet/-- The FDA has assigned a PDUFA goal date of March 29, 2023 for the NDA submission based on randomized-controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency Pharming Group N.V. ("Pharming" ...

  TargEDys and Inoliva announce they have entered a distribution... - 27 September 2022 19:15

LONGJUMEAU, France, Sept. 27, 2022, /PRNewswire-AsiaNet/-- TargEDys and Inoliva, an affiliate of Abdi Ibrahim, have signed an exclusive marketing and distribution agreement to bring Satylia, a food supplement based on the next-generation probiotic Hafnia alvei HA4597, to the Turkish market. Satylia...